Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | IMU-131 |
| Trade Name | |
| Synonyms | HER-Vaxx|IMU131|IMU 131 |
| Drug Descriptions |
IMU-131 is a B-cell vaccine comprised of 3 ERBB2 (HER2) extracellular epitopes conjugated to CRM197 (PMID: 33879458), potentially inducing polyclonal antibody response and anti-proliferative activity (PMID: 28183282). |
| DrugClasses | HER2 (ERBB2) Vaccine 15 |
| CAS Registry Number | NA |
| NCIT ID | C128283 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Capecitabine + Cisplatin + IMU-131 | Capecitabine Cisplatin IMU-131 | 0 | 0 |
| Capecitabine + IMU-131 + Oxaliplatin | Capecitabine IMU-131 Oxaliplatin | 0 | 0 |
| Cisplatin + Fluorouracil + IMU-131 | Cisplatin Fluorouracil IMU-131 | 0 | 0 |
| IMU-131 | IMU-131 | 0 | 0 |
| IMU-131 + Paclitaxel | IMU-131 Paclitaxel | 0 | 0 |
| IMU-131 + Paclitaxel + Ramucirumab | IMU-131 Paclitaxel Ramucirumab | 0 | 1 |
| IMU-131 + Pembrolizumab | IMU-131 Pembrolizumab | 0 | 1 |